Filing Details
- Accession Number:
- 0000950170-25-072801
- Form Type:
- 13G Filing
- Publication Date:
- 2025-05-14 20:00:00
- Filed By:
- Tien-Li Lee
- Company:
- Aardvark Therapeutics Inc.
- Filing Date:
- 2025-05-15
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Beneficially Owned Number of Shares | Beneficially Owned Number of Aggregate Shares | Percent of Class |
|---|---|---|---|
| Tien-Li Lee | 0 | 2,983,724 | 13.7% |
| Jane Wu Lee | 0 | 2,983,724 | 13.7% |
Filing
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13G
|
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
Aardvark Therapeutics, Inc. (Name of Issuer) |
Common Stock, par value $0.00001 (Title of Class of Securities) |
002942100 (CUSIP Number) |
03/31/2025 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule 13d-1(b)
|
| Rule 13d-1(c)
|
 Rule 13d-1(d)
|
SCHEDULE 13G
|
| CUSIP No. | 002942100 |
| 1 | Names of Reporting Persons
Tien-Li Lee | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
2,983,724.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
13.7 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: (1) Amount beneficially owned comprised of: (a) 1,496,175 shares of common stock of the Issuer owned directly by the Reporting Person, Tien-Li Lee, (b) 1,474,028 shares of common stock of the Issuer owned directly by Jane Wu Lee, the Reporting Person's spouse, and (c) 13,521 shares of common stock of the Issuer issuable upon exercise of options to purchase common stock held by the Reporting Person that are exercisable within 60 days of March 31, 2025. The Reporting Person and Jane Wu Lee are spouses and each of them may be deemed to have shared voting and dispositive power over the shares of common stock of the Issuer held by the other.
(2) Percent of class based on: (a) 21,695,920 shares of common stock of the Issuer outstanding as of March 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the Securities and Exchange Commission on May 14, 2025 (the "Form 10-Q"), plus (b) 13,521 shares of common stock of the Issuer issuable upon exercise of options to purchase common stock held by the Reporting Person that are exercisable within 60 days of March 31, 2025.
SCHEDULE 13G
|
| CUSIP No. | 002942100 |
| 1 | Names of Reporting Persons
Jane Wu Lee | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
| ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person
2,983,724.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
| ||||||||
| 11 | Percent of class represented by amount in row (9)
13.7 % | ||||||||
| 12 | Type of Reporting Person (See Instructions)
IN |
Comment for Type of Reporting Person: (1) Amount beneficially owned comprised of: (a) 1,474,028 shares of common stock of the Issuer owned directly by the Reporting Person, Jane Wu Lee, (b) 1,496,175 shares of common stock of the Issuer owned directly by Tien-Li Lee, the Reporting Person's spouse, and (c) 13,521 shares of common stock of the Issuer issuable upon exercise of options to purchase common stock held by Tien-Li Lee that are exercisable within 60 days of March 31, 2025. The Reporting Person and Tien-Li Lee are spouses and each of them may be deemed to have shared voting and dispositive power over the shares of common stock of the Issuer held by the other.
(2) Percent of class based on: (a) 21,695,920 shares of common stock of the Issuer outstanding as of March 31, 2025, as reported in the Form 10-Q, plus (b) 13,521 shares of common stock of the Issuer issuable upon exercise of options to purchase common stock held by Tien-Li Lee that are exercisable within 60 days of March 31, 2025.
SCHEDULE 13G
|
| Item 1. | ||
| (a) | Name of issuer:
Aardvark Therapeutics, Inc. | |
| (b) | Address of issuer's principal executive offices:
4370 La Jolla Village Drive, Suite 1050, San Diego, CA 92122 | |
| Item 2. | ||
| (a) | Name of person filing:
(i) Tien-Li Lee and (ii) Jane Wu Lee (together, the "Reporting Persons") | |
| (b) | Address or principal business office or, if none, residence:
c/o Aardvark Therapeutics, Inc., 4370 La Jolla Village Drive, Suite 1050, San Diego, CA 92122 | |
| (c) | Citizenship:
United States | |
| (d) | Title of class of securities:
Common Stock, par value $0.00001 | |
| (e) | CUSIP No.:
002942100 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
| |
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
| |
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
| |
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
| |
| (e) | An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
| |
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
| |
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
| |
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
| |
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
| |
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution: | |
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
| |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned:
2,983,724 shares of common stock of the Issuer, comprised of: (a) 1,496,175 shares of common stock of the Issuer owned directly by Tien-Li Lee, (b) 1,474,028 shares of common stock of the Issuer owned directly by Jane Wu Lee, and (c) 13,521 shares of common stock of the Issuer issuable upon exercise of options to purchase common stock held by Tien-Li Lee that are exercisable within 60 days of March 31, 2025. Tien-Li Lee and Jane Wu Lee are spouses and each of them may be deemed to have shared voting and dispositive power over the shares of common stock of the Issuer held by the other. | |
| (b) | Percent of class:
13.7%
Percentage based on: (a) 21,695,920 shares of common stock of the Issuer outstanding as of March 31, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, filed with the Securities and Exchange Commission on May 14, 2025, plus (b) 13,521 shares of common stock of the Issuer issuable upon exercise of options to purchase common stock held by Tien-Li Lee that are exercisable within 60 days of March 31, 2025. | |
| (c) | Number of shares as to which the person has:
| |
| (i) Sole power to vote or to direct the vote:
0 | ||
| (ii) Shared power to vote or to direct the vote:
2,983,724
See description under Item 4(a) above. | ||
| (iii) Sole power to dispose or to direct the disposition of:
0 | ||
| (iv) Shared power to dispose or to direct the disposition of:
2,983,724
See description under Item 4(a) above. | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
Not Applicable
| ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
Not Applicable
|
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
Comments accompanying signature: Exhibit 99.1 - Joint Filing Agreement